Preclinical, Clinical, and Translational Sciences
Yousuf Hussain Mohammed, Ph.D.
Associate Professor
University of Queensland
Brisbane, Queensland, Australia
Yousuf Hussain Mohammed, Ph.D.
Associate Professor
University of Queensland
Brisbane, Queensland, Australia
Khanh Phan, Ph.D. (she/her/hers)
Postdoc
University of Queensland
BRISBANE, Queensland, Australia
Vânia R. Leite-Silva, Ph.D.
Professor
Federal University of Sao Paulo
Sao Paulo, Sao Paulo, Brazil
Sangeeta Prakash, Ph.D. (she/her/hers)
Associate Professor
University of Queensland
Brisbane, Queensland, Australia
David Liu, PhD
Postdoc
University of Queensland
Brisbane, Queensland, Australia
Tannaz Ramezanli, Ph.D.
Pharmacologist
US Food and Drug Administration
Maryland, District of Columbia, United States
Priyanka Ghosh, Ph.D.
Lead Pharmacologist at Office of Research and Standards
US Food and Drug Administration
Maryland, Maryland, United States
Sam G. Raney, Ph.D. (he/him/his)
Associate Director
US Food and Drug Administration
Maryland, District of Columbia, United States
Markham C. C. Luke, Ph.D.
Director
US Food and Drug Administration
Maryland, District of Columbia, United States
Michael Roberts, Ph.D.
Professor
University of Queensland
Brisbane, Queensland, Australia
Figure 1. (a) Formulation table of 25 topical creams varied in %w/w of ammonium lauryl sulphate (highlighted in yellow), cetostearyl alcohol (highlighted in blue), poloxamer (highlighted in green), and mineral oil (highlighted in orange) composition; (b) Eight cream formulations including SC2.Ref (the reference formulation, highlighted in pink), SC2.04, SC2.13, SC2.16, SC2.18, SC2.19, SC2.20 and SC2.21 (in red font in 1.(a)), identified as C2.Ref, C2.04, C2.13, C2.16, C2.18, C2.19, C2.20 and C2.21, respectively, were selected out of 25 formulations for the sensory panel study by using statistical analyses, according to their formulation composition and a subset of CQAs.
Figure 2. Spider diagram of sensory perceptions of spreadability, cooling sensation, immediate white residue, immediate shine, immediate oiliness, stickiness, smoothness, white residue, residue shine, residue oiliness, and dry touch assessed using 9-point hedonic scale of the 4 groups of formulation variants: (a) ammonium lauryl sulphate (ALS), (b) cetostearyl alcohol (Ceto. Alco.), (c) mineral oil (Min oil), (d) poloxamer (Polox.) (formulations presented in Figure 1a), showing correlations among sensory perceptions of the cream formulation composition differences in -/+ % w/w compared with that of the reference (Ref) formulation. The number of “*” summarizes the p values/significant levels: without “*” meaning p>0.05 or no significant difference, with “*” significant difference at p<0.05, “**” significant difference at p<0.01, “***” significant difference at p<0.0005, and “****” significant difference at p<0.0001 between the cream formulations.